NS-3-008 HCl
CAS No. 1172854-54-4
NS-3-008 HCl ( —— )
产品货号. M21935 CAS No. 1172854-54-4
NS-3-008 HCl is a transcriptional G0/G1 switch 2 (G0s2) inhibitor( IC50 of 2.25 μM).Administration of NS-3-008 inhibited the expression of G0s2 in healthy mice liver.?
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥324 | 有现货 |
|
5MG | ¥518 | 有现货 |
|
10MG | ¥786 | 有现货 |
|
25MG | ¥1426 | 有现货 |
|
50MG | ¥2398 | 有现货 |
|
100MG | ¥3588 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NS-3-008 HCl
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NS-3-008 HCl is a transcriptional G0/G1 switch 2 (G0s2) inhibitor( IC50 of 2.25 μM).Administration of NS-3-008 inhibited the expression of G0s2 in healthy mice liver.?
-
产品描述NS-3-008 HCl is a transcriptional G0/G1 switch 2 (G0s2) inhibitor( IC50 of 2.25 μM).Administration of NS-3-008 inhibited the expression of G0s2 in healthy mice liver.?In contrast, administration of NS-3-008 did not affect the MBP in wild-type sham and 5/6Nx mice.?NS-3-008 as a novel G0s2 inhibitor and showed that administration of this inhibitor ameliorated renal dysfunction in wild-type 5/6Nx mice.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体G0s2
-
研究领域——
-
适应症——
化学信息
-
CAS Number1172854-54-4
-
分子量269.81
-
分子式C14H24ClN3
-
纯度>98% (HPLC)
-
溶解度DMSO:120 mg/ml(444.76 mM; Need ultrasonic);H2O : 125 mg/mL (463.29 mM; Need ultrasonic)
-
SMILESCl.CCCCCCNC(=N)NCc1ccccc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Matsunaga N, et al. Inhibition of G0/G1 Switch 2 Ameliorates Renal Inflammation in Chronic Kidney Disease. EBioMedicine. 2016 Nov;13:262-273.
产品手册
关联产品
-
Allopurinol riboside
Allopurinol riboside is a metabolite of allopurinol with potency against parasites.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
MRS 2578
MRS2578, an effective P2Y6 receptor antagonist with IC50 of 37 nM, shows insignificant inhibition at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.